Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Biochemical Pharmacology|March 29, 1994
5-ethynyl-2(1H)-pyrimidinone: aldehyde oxidase-activation to 5-ethynyluracil, a mechanism-based inactivator of dihydropyrimidine dehydrogenaseD J Porter, J A Harrington, M R Almond, et al.MMWR. Morbidity and Mortality Weekly Report|November 18, 2021
Automated Digital Notification of COVID-19 Diagnoses Through Text and Email Messaging - North Carolina, December 2020-January 2021Laura Farrell, Crystal R Almond, Deborah S Porterfield, et al.Epidemiology and Infection|March 15, 2019
Associations between antibiotic prescriptions and recurrent urinary tract infections in female college studentsS N Rich, E M Klann, C R Almond, et al.Genetics|August 28, 2013
Coordination and processing of DNA ends during double-strand break repair: the role of the bacteriophage T4 Mre11/Rad50 (MR) complexJoshua R Almond, Bradley A Stohr, Anil K Panigrahi, et al.Nucleosides, Nucleotides & Nucleic Acids|January 5, 2005
Synthesis of (-)-DAPDMarcos L Sznaidman, Jinfa Du, Amir Pesyan, et al.Medical Physics|August 1, 1994
The calibration and use of plane-parallel ionization chambers for dosimetry of electron beams: an extension of the 1983 AAPM protocol report of AAPM Radiation Therapy Committee Task Group No. 39P R Almond, F H Attix, L J Humphries, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 1983
Late effects of 50 MeV d leads to Be neutron and cobalt-60 irradiation of rhesus monkey cervical spinal cordL C Stephens, D H Hussey, G L Raulston, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1990
Shielding considerations for an operating room based intraoperative electron radiotherapy unitM D Mills, P R Almond, A L Boyer, et al.Diabetes, Obesity & Metabolism|September 20, 2014
Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetesA P Sykes, G L Kemp, R Dobbins, et al.Journal of Medicinal Chemistry|August 3, 1992
2-Substituted 1-azabicycloalkanes, a new class of non-opiate antinociceptive agentsJ R Carson, R J Carmosin, J L Vaught, et al.Pageof 9